• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于N6-甲基腺苷相关长链非编码RNA谱的肝细胞癌分类

Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine-Related lncRNAs Profiling.

作者信息

Yin Lu, Zhou Liuzhi, Gao Shiqi, Feng Yina, Zhu Hanzhang, Xiang Jingjing, Xu Rujun

机构信息

Department of Pathology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Department of Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Front Mol Biosci. 2022 Feb 4;9:807418. doi: 10.3389/fmolb.2022.807418. eCollection 2022.

DOI:10.3389/fmolb.2022.807418
PMID:35187083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8854774/
Abstract

HCC is one of the most common types of malignancies worldwide and the fourth-leading cause of cancer deaths. Thus, there is an urgent need to search for novel targeted therapies in HCC. 186 m6a-related lncRNAs were screened for subsequent analysis. Two distinct m6A modification clusters were identified to be associated with the overall prognosis in TCGA-LIHC based on the m6A-related lncRNAs profiling, followed by univariate Cox regression analysis. In addition, four m6A-related lncRNAs prognostic signatures were developed and validated that could predict the OS of HCC patients, followed by univariate Cox regression, LASSO regression, and multivariate Cox regression analysis. Moreover, four m6A-related lncRNAs were identified to be related to HCC prognosis. ESTIMATE was used to evaluate the stromal score, immune score, ESTIMATE score, and tumor purity of each HCC sample. ssGSEA was performed to identify the enrichment levels of 29 immune signatures in each sample. Finally, quantitative real-time polymerase chain reaction shown that KDM4A-AS1, BACE1-AS, and NRAV expressions were upregulated in HCC patients. We proved that our m6A-related lncRNAs signature had powerful and robust ability for predicting OS of different HCC subgroups.

摘要

肝癌是全球最常见的恶性肿瘤类型之一,也是癌症死亡的第四大主要原因。因此,迫切需要在肝癌中寻找新的靶向治疗方法。筛选了186个与m6A相关的长链非编码RNA用于后续分析。基于与m6A相关的长链非编码RNA谱,在TCGA-LIHC中鉴定出两个不同的m6A修饰簇与总体预后相关,随后进行单变量Cox回归分析。此外,开发并验证了四个与m6A相关的长链非编码RNA预后特征,可预测肝癌患者的总生存期,随后进行单变量Cox回归、LASSO回归和多变量Cox回归分析。此外,鉴定出四个与m6A相关的长链非编码RNA与肝癌预后相关。使用ESTIMATE评估每个肝癌样本的基质评分、免疫评分、ESTIMATE评分和肿瘤纯度。进行单样本基因集富集分析(ssGSEA)以确定每个样本中29种免疫特征的富集水平。最后,定量实时聚合酶链反应显示,肝癌患者中KDM4A-AS1、BACE1-AS和NRAV的表达上调。我们证明,我们的与m6A相关的长链非编码RNA特征对预测不同肝癌亚组的总生存期具有强大而稳健的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/15b18998e1a2/fmolb-09-807418-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/369ee5f1b6ef/fmolb-09-807418-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/f744b873db6f/fmolb-09-807418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/db44432d2844/fmolb-09-807418-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/175eedd7019f/fmolb-09-807418-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/862c7e2b3118/fmolb-09-807418-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/3d62fe2e6693/fmolb-09-807418-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/219e0dbb17ad/fmolb-09-807418-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/15b18998e1a2/fmolb-09-807418-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/369ee5f1b6ef/fmolb-09-807418-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/f744b873db6f/fmolb-09-807418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/db44432d2844/fmolb-09-807418-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/175eedd7019f/fmolb-09-807418-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/862c7e2b3118/fmolb-09-807418-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/3d62fe2e6693/fmolb-09-807418-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/219e0dbb17ad/fmolb-09-807418-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336c/8854774/15b18998e1a2/fmolb-09-807418-g008.jpg

相似文献

1
Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine-Related lncRNAs Profiling.基于N6-甲基腺苷相关长链非编码RNA谱的肝细胞癌分类
Front Mol Biosci. 2022 Feb 4;9:807418. doi: 10.3389/fmolb.2022.807418. eCollection 2022.
2
M6A-related lncRNAs predict clinical outcome and regulate the tumor immune microenvironment in hepatocellular carcinoma.M6A 相关长链非编码 RNA 预测肝细胞癌的临床结局并调节肿瘤免疫微环境。
BMC Cancer. 2022 Aug 9;22(1):867. doi: 10.1186/s12885-022-09925-2.
3
An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma.一种与m6A相关的长链非编码RNA特征可预测肝细胞癌的预后。
Front Pharmacol. 2022 Mar 30;13:854851. doi: 10.3389/fphar.2022.854851. eCollection 2022.
4
N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.N6-甲基腺苷相关长链非编码 RNA 在胰腺导管腺癌的预后和免疫微环境中发挥重要作用。
Sci Rep. 2021 Sep 8;11(1):17844. doi: 10.1038/s41598-021-97362-9.
5
Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.鉴定 m6A 甲基转移酶相关的长链非编码 RNA 特征,以预测肝细胞癌患者的免疫治疗和预后。
Biosci Rep. 2021 Jun 25;41(6). doi: 10.1042/BSR20210760.
6
N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.N6-甲基腺苷相关长链非编码RNA是预测低级别胶质瘤患者总生存期的潜在生物标志物。
Front Cell Dev Biol. 2020 Jul 23;8:642. doi: 10.3389/fcell.2020.00642. eCollection 2020.
7
Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.N6-甲基腺苷相关长链非编码RNA与肺腺癌肿瘤免疫微环境及临床预后的关系
Front Genet. 2021 Oct 20;12:714697. doi: 10.3389/fgene.2021.714697. eCollection 2021.
8
Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.卵巢癌患者中参与m6A调控的长链非编码RNA的鉴定与验证
Cancer Cell Int. 2021 Jul 8;21(1):363. doi: 10.1186/s12935-021-02076-7.
9
Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients.鉴定与N6-甲基腺苷相关的长链非编码RNA特征以预测结直肠癌患者的预后和治疗反应
Front Genet. 2022 Sep 30;13:947747. doi: 10.3389/fgene.2022.947747. eCollection 2022.
10
N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer.N6-甲基腺苷相关长链非编码RNA预测膀胱癌的预后和免疫治疗反应
Front Oncol. 2021 Aug 11;11:710767. doi: 10.3389/fonc.2021.710767. eCollection 2021.

引用本文的文献

1
Clinical potential and experimental validation of prognostic genes in hepatocellular carcinoma revealed by risk modeling utilizing single cell and transcriptome constructs.利用单细胞和转录组构建体进行风险建模揭示的肝细胞癌预后基因的临床潜力和实验验证。
Front Immunol. 2025 Apr 4;16:1541252. doi: 10.3389/fimmu.2025.1541252. eCollection 2025.
2
Integrated multi-omics analysis and machine learning refine molecular subtypes and clinical outcome for hepatocellular carcinoma.综合多组学分析与机器学习优化肝细胞癌的分子亚型及临床预后。
Hereditas. 2025 Apr 12;162(1):61. doi: 10.1186/s41065-025-00431-6.
3
Identification of cuproptosis-related long non-coding RNA and construction of a novel prognostic signature for bladder cancer: An observational study.

本文引用的文献

1
The role of MA modification in the regulation of tumor-related lncRNAs.MA修饰在肿瘤相关长链非编码RNA调控中的作用。
Mol Ther Nucleic Acids. 2021 Apr 9;24:768-779. doi: 10.1016/j.omtn.2021.04.002. eCollection 2021 Jun 4.
2
METTL3 Regulates Ossification of the Posterior Longitudinal Ligament via the lncRNA XIST/miR-302a-3p/USP8 Axis.METTL3通过lncRNA XIST/miR-302a-3p/USP8轴调控后纵韧带骨化
Front Cell Dev Biol. 2021 Mar 5;9:629895. doi: 10.3389/fcell.2021.629895. eCollection 2021.
3
Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N-methyladenosine of PARP1 mRNA and downregulating PTEN.
铜死亡相关长链非编码RNA的鉴定及膀胱癌新预后特征的构建:一项观察性研究
Medicine (Baltimore). 2024 May 3;103(18):e38005. doi: 10.1097/MD.0000000000038005.
4
Investigation of the feasibility of NRAV as a biomarker for hepatocellular carcinoma.探讨 NRAV 作为肝细胞癌生物标志物的可行性。
Oncol Res. 2024 Mar 20;32(4):717-726. doi: 10.32604/or.2023.043575. eCollection 2024.
5
Machine learning-based integration develops a neutrophil-derived signature for improving outcomes in hepatocellular carcinoma.基于机器学习的整合开发了一种中性粒细胞衍生的特征,以改善肝细胞癌的预后。
Front Immunol. 2023 Jul 28;14:1216585. doi: 10.3389/fimmu.2023.1216585. eCollection 2023.
6
Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer.基于机器学习构建铁死亡和坏死性凋亡相关lncRNA特征以预测肝细胞癌的预后和免疫治疗反应
Front Oncol. 2023 Apr 20;13:1171878. doi: 10.3389/fonc.2023.1171878. eCollection 2023.
7
E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA.E2F1 介导的 KDM4A-AS1 上调通过募集 ILF3 稳定 AURKA mRNA 促进肝癌细胞 EMT。
Cancer Gene Ther. 2023 Jul;30(7):1007-1017. doi: 10.1038/s41417-023-00607-0. Epub 2023 Mar 27.
8
Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma.全面分析铜死亡相关 lncRNAs 对肝细胞癌的预后意义和免疫微环境特征。
Front Immunol. 2023 Jan 4;13:991604. doi: 10.3389/fimmu.2022.991604. eCollection 2022.
9
Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma.全面分析肝细胞癌中铜死亡相关 lncRNAs 与免疫浸润和预后的关系。
BMC Bioinformatics. 2023 Jan 3;24(1):4. doi: 10.1186/s12859-022-05091-1.
10
Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma.m6A和长链非编码RNA在肝细胞癌预后及免疫治疗中的作用分析
Heliyon. 2022 Sep 14;8(9):e10612. doi: 10.1016/j.heliyon.2022.e10612. eCollection 2022 Sep.
TRAF3IP2-AS1 低表达通过刺激 PARP1 mRNA 的 N-甲基腺苷化和下调 PTEN 促进 NONO-TFE3 易位肾细胞癌的进展。
J Hematol Oncol. 2021 Mar 19;14(1):46. doi: 10.1186/s13045-021-01059-5.
4
mA-Mediated Upregulation of LINC00857 Promotes Pancreatic Cancer Tumorigenesis by Regulating the miR-150-5p/E2F3 Axis.mA介导的LINC00857上调通过调控miR-150-5p/E2F3轴促进胰腺癌肿瘤发生。
Front Oncol. 2021 Feb 18;11:629947. doi: 10.3389/fonc.2021.629947. eCollection 2021.
5
Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.基于九个免疫相关长链非编码RNA的低级别胶质瘤个体化预后标志物的鉴定与验证
Clin Neurol Neurosurg. 2021 Feb;201:106464. doi: 10.1016/j.clineuro.2020.106464. Epub 2021 Jan 5.
6
New advances in the diagnosis and management of hepatocellular carcinoma.肝细胞癌的诊断与治疗新进展。
BMJ. 2020 Oct 26;371:m3544. doi: 10.1136/bmj.m3544.
7
m6A RNA Methylation: Ramifications for Gene Expression and Human Health.m6A RNA 甲基化:对基因表达和人类健康的影响。
Mol Biotechnol. 2020 Oct;62(10):467-484. doi: 10.1007/s12033-020-00269-5. Epub 2020 Aug 25.
8
Functions of N6-methyladenosine and its role in cancer.N6-甲基腺苷的功能及其在癌症中的作用。
Mol Cancer. 2019 Dec 4;18(1):176. doi: 10.1186/s12943-019-1109-9.
9
Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the mA reader YTHDF3.长链非编码 RNA GAS5 通过与 YAP 相互作用并触发其磷酸化和降解来抑制结直肠癌的进展,并且受到 mA 阅读器 YTHDF3 的负调控。
Mol Cancer. 2019 Oct 16;18(1):143. doi: 10.1186/s12943-019-1079-y.
10
A global view of hepatocellular carcinoma: trends, risk, prevention and management.全球视角下的肝细胞癌:趋势、风险、预防与管理。
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604. doi: 10.1038/s41575-019-0186-y. Epub 2019 Aug 22.